Open house discount contracts for Metformin/Dapagliflozin
Original notice title
Germany – Pharmaceutical products – Open House Originale Rabattverträge 2025-20 - Metformin/Dapagliflozin (Wirkstoffkombination)
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No estimated contract value or volume is provided, making it impossible to assess potential revenue.
Contract automatically ends upon patent expiry or loss of market exclusivity, which could occur before the planned end...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 2 lots
- Duration until Jul 2027
- Conclusion of discount agreements (Rabattverträge) for the fixed combination Metformin/Dapagliflozin
- Contract term of maximum 24 months starting 01.08.2025, ending no later than 31.07.2027
Show full summary
Open House Originale procedure by Techniker Krankenkasse (TK) for discount agreements on the fixed combination Metformin/Dapagliflozin (active substance combination) under §130c SGB V. The procedure is open to all eligible pharmaceutical entrepreneurs offering this drug. Contracts have uniform conditions, no exclusivity, and a maximum term of 24 months (01.08.2025 to 31.07.2027), subject to early termination upon patent expiry. Joining is possible at any time during the contract period. Submission is via email with qualified electronic signature or by post.
Risks
No estimated contract value or volume is provided, making it impossible to assess potential revenue.
Contract automatically ends upon patent expiry or loss of market exclusivity, which could occur before the planned end...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (Pharmazeutischer Unternehmer) as defined in §4 Abs. 18 AMG
- Must have a valid marketing authorization for the specific drug or equivalent right to place it on the market
- Seat must be in Germany, another EU member state, or an EEA state
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (2)
LOT-0001
No Lot Division
Discount agreement for the fixed combination Metformin/Dapagliflozin. Open to all eligible pharmaceutical entrepreneurs. Uniform conditions, no exclusivity. Contract term max 24 months from 01.08.2025, ending 31.07.2027. Joining possible anytime.
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Metformin/Dapagliflozin (Wirkstoffkombination) zu schließen.
Value note
Show original TED data
Original lot title
keine Losaufteilung
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Metformin/Dapagliflozin (Wirkstoffkombination) zu schließen.
LOT-0002
No Lot Split
Discount agreement for the fixed combination Metformin/Dapagliflozin. Open to all eligible pharmaceutical entrepreneurs. Uniform conditions, no exclusivity. Contract term max 24 months from 01.08.2025, ending 31.07.2027. Joining possible anytime.
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Metformin/Dapagliflozin (Wirkstoffkombination) zu schließen.
Value note
Show original TED data
Original lot title
keine Losteilung
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zur Wirkstoffkombination Metformin/Dapagliflozin (Wirkstoffkombination) zu schließen.
Procurement Details
- Publication date
- 19 May 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 324600-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
60 / 100
Complexity
30 / 100
Risk factors
No estimated contract value or volume is provided, making it impossible to assess potential revenue.
Contract automatically ends upon patent expiry or loss of market exclusivity, which could occur before the planned end...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications